The rare lung disease is so complicated that its acronym is difficult to pronounce. However, for infants who were unfortunate enough to be born with this disorder, the outcome is generally fatal.
Left: normal mouse lung tissue showing a healthy density of blood vessels. Middle: example of abnormal, diseased tissue with reduced STAT3 activation. Right: tissue from a treated mouse. Green depicts blood vessels; Red shows activated STAT3. Image Credit: Cincinnati Children’s.
The disease is known as alveolar capillary dysplasia with misalignment of the pulmonary veins, or ACDMPV for short. According to a study, the disease is associated with mutations in the FOXF1 gene. Medical experts throughout the world have recorded around 200 cases, but an unestimated number of infants could have died without the disorder ever being diagnosed, stated the National Organization for Rare Disorders.
The disease is induced by genetic changes that inhibit the formation of proper blood vessels in the lungs. Within a few days or weeks post birth, infants turn blue because of the absence of oxygen while blood pressure increases inside their lungs. The few infants who get to live do so by receiving exceptionally rare infant-sized lung transplants.
Now, a new study headed by experts from Cincinnati Children’s and the University of Cincinnati has reported about helping mice (with a FOXF1 mutation that is identical to human ACDMPV patients) live longer with this fatal disease. This was done by applying high-tech nanoparticles to send a STAT3 gene into the lungs to trigger the growth of blood vessels.
STAT3 is a crucial downstream target of the FOXF1 gene and its delivery can rectify the vascular deficiency in ACDMPV mice. The study results were published online in the Circulation journal on June 11th, 2021.
If these findings can be matched in human analyses in the future, this success can potentially boost the speed of development for other nanoparticle-based treatments for many medical conditions, stated the study co-authors….
Scientists have worked out how to best get DNA to communicate with membranes in our body, paving the way for the creation of ‘mini biological computers’ in droplets that have potential uses in biosensing [...]
Reactive oxygen species (ROS) exhibit the potential to act as signal carriers during the development of malignant tumors. At a suitable concentration, ROS tends to mediate cell growth and signal transduction. But ROS are [...]
One of the biggest challenges when it comes to probing and manipulating the brain are the blunt tools we have at our disposal. But breakthroughs in nanotechnology could soon change that, say researchers. Neuroscience has [...]
When liquid meets gas, a unique zone forms. Variable by nature, molecules can cross from one state to another, combining in unique ways to either desirable or unwanted ends. From heat escaping a mug [...]
A newly detected coronavirus variant is on the rise in England, with the virus believed to be an offshoot of Delta. According to a briefing from the UK Health Security Agency, released on Friday, [...]
A team of researchers has developed a new nanomechanical technique for fast, one-step, immune-affinity tests, which can quantify the immune response induced by different COVID-19 variants in serum. Their technique provides a new tool [...]
Lawrence Livermore National Laboratory (LLNL) scientists have developed a new method for 3D printing living microbes in controlled patterns, expanding the potential for using engineered bacteria to recover rare-earth metals, clean wastewater, detect uranium, [...]
Nanomedicines may offer clinicians a way to deliver precise, targeted therapy directly to tumors without damaging surrounding tissue. Yet, progress in the development of new drugs that treat cancer at the nanoparticle level has [...]
Cambridge researchers have discovered how T cells—an important component of our immune system—are able keep on killing as they hunt down and kill cancer cells, repeatedly reloading their toxic weapons. Cytotoxic T [...]
Sunday, October 3, set records for the most COVID-19 deaths in Russia on a single day. Only 29% of people in Russia are vaccinated, despite the country being the first to approve a vaccine. [...]
New research from the University of Technology Sydney (UTS) has found that pathogens that form biofilms can evolve to survive nanosilver treatment. The study is the first to demonstrate that long-term nanosilver treatment can [...]
New variants of SARS-CoV-2 are more virulent and transmissible than the original variant of the virus. Health experts associate these variants of concern (VOCs) with increased risk of hospitalization, intensive care unit (ICU) admission, [...]
Freeze-dried genetic circuits could reveal the presence of SARS-CoV-2, Ebola, MRSA, and more. Masks and testing have been key to the COVID-19 pandemic response—and now devices that combine the two may be on the [...]
Hundreds of neuroscientists built a ‘parts list’ of the motor cortex, laying groundwork to map the whole brain and better understand brain diseases. Before you read any further, bring your hand to your forehead. [...]
An international team, led by Swinburne University of Technology and Australian National University (ANU), have made a breakthrough discovery that could potentially lead to faster, more accurate molecular or virus tests, including for COVID-19. [...]